Symrise to sell AmeriTerpenes terpene business to Mutares

Key highlights
  • Symrise signed a definitive agreement to sell AmeriTerpenes LLC to Mutares SE & Co. KGaA, with signing and closing occurring simultaneously.
  • AmeriTerpenes operates US manufacturing sites in Jacksonville, Florida and Colonels Island, Georgia, supplying renewable terpene ingredients for fragrance, flavor and industrial uses.
  • Symrise and AmeriTerpenes will continue a long-standing commercial relationship with agreed supply arrangements securing long-term access to renewable terpene raw materials.
  • Symrise expects a mid-double-digit million-euro non-cash disposal loss that will be reflected in its 2026 annual financial statements; financial terms were kept confidential.

Deal overview

Symrise AG has signed a definitive agreement to sell AmeriTerpenes LLC, its terpene ingredients business, to Mutares SE & Co. KGaA. The signing and closing took place simultaneously and both parties agreed to keep financial details confidential.

Assets and operations

AmeriTerpenes is a producer of renewable terpene ingredients serving fragrance, flavor and industrial applications from US manufacturing sites in Jacksonville, Florida and Colonels Island, Georgia. An operational carve-out completed over recent months has positioned the business to continue development under new ownership.

Strategic rationale

Symrise says the divestiture sharpens its portfolio and concentrates management attention on core growth platforms under the ONE Symrise strategy while supporting its ambition for sustainable profitable growth, operational excellence and disciplined capital allocation. Mutares frames the deal as a new platform investment in its Chemicals & Materials segment and a strengthening of its U.S. footprint.

Transition and financial impact

Both parties committed to ensuring a seamless transition, business continuity and strong customer and supplier relationships; Symrise and AmeriTerpenes will continue their long-standing commercial relationship and agreed supply arrangements. Symrise expects a non-cash disposal loss in the mid-double-digit million-euro range to be reflected in its 2026 annual financial statements. Symrise was advised by Stifel, Alvarez & Marsal and Troutman Pepper Locke.

Source: Symrise

chemXplore Weekly

The week’s most important chemical-industry moves — analysed and summarised — delivered free every Wednesday.

Free. One email a week. Unsubscribe any time.